soul trial oral semaglutide cardiovascular outcomes 2024 2025 results (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Oral Semaglutide Lowers Cardiovascular Events

Kybella permanently destroys fat cells, although you can still gain weight again if you do not stick to a healthy diet and exercise routine

Bringing Oral GLP-1 Programs to Life with OptiMantra The approval of the first oral GLP-1 for weight loss marks a pivotal moment for medical spas and wellness clinics

Peptides for Anti-Aging Peptides are also widely studied in the field of longevity and anti-aging medicine

Because food supplements are not subject to the same pre-market approval requirements as licensed medicines, manufacturers are not required to demonstrate clinical efficacy or safety to the same rigorous standard

Knowing what to avoid while taking ibuprofen is essential for your safety

More discipline will prevent regain. Rebound is biological, not behavioral